Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty

Circulation

Volumn 91, Issue 5, 1995, Pages 1403-1409

  Desmarais, Rene L ^a   Sarembock, Ian J ^a   Ayers, Carlos R ^a   Vernon, Sarah M ^a   Powers, Eric R ^a   Gimple, Lawrence W ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

angioplasty; lipids; lipoproteins

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ARTICLE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; FEMALE; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; STATISTICAL ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0028941169     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.91.5.1403     Document Type: Article

References (54)

1. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986;4:758-765.
2. Abe A, Noma A, Lee YJ, Yamaguchi H. Studies on apolipoprotein(a) phenotypes, 2: phenotype frequencies and Lp(a) concentrations in different phenotypes in patients with angiographically defined coronary artery diseases. Atherosclerosis. 1992;96:9-15.
3. Vella JC, Jover E. Relation of lipoprotein(a) in 11- to 19-year-old adolescents to parental cardiovascular heart disease. Clin Chem. 1993;39:477-480.
4. Labeur C, De Bacquer D, De Backer G, Vincke J, Muyldermans L, Vandekerckhove Y, Van der Stichele E, Rosseneu M. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. Clin Chem. 1992;38:2261-2266.
5. Cambillau M, Simon A, Amar J, Giral P, Atger V, Segond P, Levenson J, Merli I, Megnien JL, Plainfosse MC. Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men: the PCVMETRA Group. Arterioscler Thromb. 1992;12:1346-1352.
6. Tyrrell J, Cooke T, Reilly M, Colgan M, Moore D, Shanik DG, Bergin C, Feely J. Lipoprotein(a) [Lp(a)] and peripheral vascular disease. J Intern Med. 1992;232:349-352.
7. Watts GF, Kearney EM, Taub NA, Slavin BM. Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia. J Clin Pathol. 1993;46:267-270.
8. Muller HM, Diekstall FF, Schmidt E, Marz W, Canzler H, Demeler U. Lipoprotein(a): a risk factor for retinal vascular occlusion. Ger J Ophthalmol. 1992;1:338-341.
9. Williams JK, Bellinger DA, Nichols TC, Griggs TR, Bumol TF, Fouts RL, Clarkson TB. Occlusive arterial thrombosis in cynomolgus monkeys with varying plasma concentrations of lipoprotein(a). Arterioscler Thromb. 1993;13:548-554.
10. Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, Hoppichler F, Boerwinkle E, Utermann G. Apo(a) isoforms predict risk for coronary heart disease: a study in six populations. Arterioscler Thromb. 1992;12:1214-1226.
11. Haffner SM, Gruber KK, Morales PA, Hazuda HP, Valdez RA, Mitchell BD, Stern MP. Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Epidemiol. 1992;136:1060-1068.
12. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis. 1990;10:240-245.
13. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature. 1989;339:303-305.
14. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature. 1989;339:301-303.
15. Moliterno DJ, Lange RA, Meidell RS, Willard JE, Leffert CC, Gerard RD, Boerwinkle E, Hobbs HH, Hillis LD. Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction. Circulation. 1993;88:935-940.
16. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science. 1993;260:1655-1658.
17. Hearn JA, Donohue BC, Ba'alkaki H, Douglas JS, King SPI, Lembo NJ, Roubin GS, Sgoutas DS. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1992;69:736-739.
18. Shah PK, Amin J. Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty. Circulation. 1992;85:1283-1288.
19. Maeda S, Abe A, Seishma M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis. 1989;78:145-150.
20. ++ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1386.
21. Berger BC, Watson DD, Taylor GJ, Craddock GB, Martin RP, Teates CD, Beller GA. Quantitative thallium-201 exercise scintigraphy for detection of coronary artery disease. J Nucl Med. 1981;22:585-593.
22. Watson DD, Campbell NP, Read EK, Gibson RS, Teates CD, Beller GA. Spatial and temporal quantitation of planar thallium myocardial images. J Nucl Med. 1981;22:577-584.
23. Mood AM, Graybill FA. Introduction to the Theory of Statistics. New York, NY: McGraw Hill Co; 1963.
24. Albert A. On the use and computation of likelihood ratios in clinical chemistry. Clin Chem. 1982;28:1113-1119.
25. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP, Schaefer EJ. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels: the Framingham Offspring Study. Circulation. 1993;87:1135-1141.
26. Sgoutas DS, Tuten T. Effect of freezing and thawing of serum on the immunoassay of liproprotein(a). Clin Chem. 1992;38:1873-1877.
27. Craig WY, Poulin SE, Forster NR, Neveux LM, Wald NJ, Ledue TB. Effect of sample storage on the assay of lipoprotein(a) by commercially available radial immunodiffusion and enzyme-linked immunosorbent assay kits. Clin Chem. 1992;38:550-553.
28. Cooke T, Sheahan R, Foley D, Reilly M, D'Arcy G, Jauch W, Gibney M, Gearty G, Crean P, Walsh M. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease. Circulation. 1994;89:1593-1598.
29. Reis GA, Kuntz RE, Silverman DI, Pasternak RC. Effects of serum lipid levels on restenosis after coronary angioplasty. Am J Cardiol. 1991;68:1431-1435.
30. Rensing BJ, Hermans WRM, Vos J, Tijssen JGP, Rutch W, Danchin N, Heyndrickx GR, Mast G, Wijns W, Serruys PW. Luminal narrowing after percutaneous transluminal coronary angioplasty. Circulation. 1993;88:975-985.
31. Bourassa MG, Lesperance J, Eastwood C, Schwartz L, Cote G, Kazim F, Hudon G. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty: clinical and angiographie follow-up. J Am Coll Cardiol. 1991;18:246-252.
32. Vandormael MG, Deligonul U, Kern MJ, Harper M, Presant S, Gibson P, Galan K, Chaitman BR. Multilesion coronary angioplasty: clinical and angiographic follow-up. J Am Coll Cardiol. 1987;10:246-252.
33. Holmes DRJ, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruntzig AR, Kelsey SF, Setre KM, Van Raden MJ, Mock MB. Restenosis after percutaneous transluminal coronary angioplasty: a report from the PTCA registry of the National Heart, Lung and Blood Institute. Am J Cardiol. 1984;53: 77C-81C.
34. Lambert M, Bonan R, Cote G, Crepeau J, de Guise P, Lesperance J, David PR, Waters DD. Multiple coronary angioplasty: a model to discriminate systemic and procedural factors related to restenosis. J Am Coll Cardiol. 1988;12:310-314.
35. Fleck E, Regitz C, Lehnert A, Dacian S, Dirschinger J, Rudolf W. Restenosis after balloon dilatation of coronary stenosis: multivariate analysis of potential risk factors. Eur Heart J. 1988;9:15-18.
36. Ellis SG, Roubin GS, King SB III, Douglas JSJ, Cox WR. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty. Am J Cardiol. 1989;63:30-34.
37. Galan KM, Hollman JL. Recurrence of stenosis after coronary angioplasty. Heart Lung. 1986;15:585-587.
38. Arora RR, Konrad K, Badhwar K, Hollman JL. Restenosis after transluminal coronary angioplasty: a risk factor analysis. Cathet Cardiovasc Diagn. 1990;19:17-22.
39. Macdonald RG, Henderson MA, Hirschfeld JW Jr, Goldberg SH, Bass T, Vetrovec G, Cowley M, Taussig A, Whitworth H, Margolis JR, Hill JA, Jugo R, Pepine CJ. Patient related variables and restenosis after percutaneous transluminal coronary angioplasty: a report from the M-heart group. Am J Cardiol. 1990;66:926-931.
40. Graziani MS, Zanolla L, Righetti G, Nicoli M, Modena N, Dimitri G, Menegatti G, Vassanelli C. Lipoprotein(a) concentrations are increased in patients with myocardial infarction and angiographically normal coronary arteries. Eur J Clin Chem Clin Biochem. 1993;31:135-137.
41. Smith EB, Cochran S. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. Arteriosclerosis. 1990;84:173-181.
42. Schwartz RS, Holmes DJ, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992;20:1284-1293.
43. McNamara CA, Sarembock IJ, Gimple LW, Fenton IJ, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993;91:94-98.
44. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA. 1992;82:2317-2320.
45. Beatt KJ, Serruys PW, Hugenholtz PG. Restenosis after coronary angioplasty: new standards for clinical studies. J Am Colt Cardiol. 1990;15:491-498.
46. Kuntz RE, Gibson CM, Nobuyoshi M, Bairn DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol. 1993;21:15-25.
47. Serruys P, Luijten H, Beatt K, Geuskens R, de Feyter P, van den Brand M, Reiber J, ten Katen H, van Es G, Hugenholtz P. Incidence of restenosis after successful coronary angioplasty: a time related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation. 1988; 7:361-371.
48. Kuntz RE, Baim DS. Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation. 1993;88:1310-1323.
49. Gordon PC, Friedrich SP, Piana RN, Kugelmass AD, Leidig GA, Gibson CM, Cohen DJ, Carrozza JP, Kuntz RE, Baim DS. Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant? Am J Cardiol. 1994;74:26-32.
50. Albers JJ, Marcovins SM, Lodge MS. The unique lipoprotein (a) properties and immunochemical measurement. Clin Chem. 1990;36:2019-2026.
51. Utermann G. The mysteries of lipoprotein (a). Science. 1989; 2456:904-910.
52. Guyton JR, Dahlen GH, Patsch W, Kautz JA, Gotto AM Jr. Relationship of plasma lipoprotein LP(a) levels to race and to apolipoprotein B. Arteriosclerosis. 1985;5:265-272.
53. Parra HJ, Luyeye I, Bouramoue C, Dermarquilly C, Fruchart JC. Black-white differences in serum Lp(a) lipoprotein levels. Clin Chim Acta. 1987;167:27-31.
54. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenston GS. Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardia infarction in children. Circulation. 1991;94:160-167.